Sertraline Hcl Capsule
Product Images NDC 69238-2789
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Sertraline Hcl (NDC 69238-2789). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Amneal Pharmaceuticals Ny Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
150 mg Label (Sertraline HCl Capsules 2)
The text is about a medication capsule containing Sertraline HCI, distributed by Amneal Pharmaceuticals LLC. The recommended dosage is equivalent to 150 mg of Sertraline. It advises to store the capsules between 15°C to 30°C and contains FD&C Yellow No. 5 as a color additive. Additionally, it instructs pharmacists to dispense the prescribing information along with the medication guide to each patient.*
200 mg Label (Sertraline HCl Capsules 3)
This text contains information about a medication with the active ingredient Sertraline HCI, each capsule equivalent to 200 mg of sertraline. The manufacturer is Ritsa Pharma Private Limited in Hyderabad, India, and it is distributed by Amneal Pharmaceuticals LLC in Bridgewater, NJ. The recommended dosage and storage information are also included. It is essential to consult the prescribing information and medication guide before use.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.